420 Magazine Background

endocannabinoid

  1. G

    New member - Myelofibrosis patient

    I use cannabis for relief of numerous symptoms caused by my bone marrow cancer, myelofibrosis (anyone else with MF here?) The funniest thought came through my head, though you have to understand the endocannabinoid system for it to make sense. I am very allergic to yellow jackets. I stepped...
  2. Richard Richardson

    A Cannabinoid Enhancer In Your Medicine Cabinet?

    An endocannabinoid enhancer (eCBE) is a type of cannabinoidergic drug that enhances the activity of the endocannabinoid system by increasing extracellular concentrations of endocannabinoids. An example of an actual eCBE is AM404, the active metabolite of the analgesic Paracetamol...
  3. Julie Gardener

    Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

    Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation Sumner H. Burstein and Robert B. Zurier AAPS J. 2009 March Abstract This review covers reports published in the last 5 years on the anti-inflammatory activities of all classes of cannabinoids, including phytocannabinoids...
  4. Julie Gardener

    Anti-Dyskinetic Effects Of Cannabinoids In A Rat Model Of Parkinson's Disease

    Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors Maria Grazia Morgese, Tommaso Cassano, Vincenzo Cuomo, and Andrea Giuffrida Exp Neurol. 2007 November Abstract Levodopa is the most commonly prescribed drug for Parkinson's...
  5. Julie Gardener

    Cannabinoids and the Endocannabinoid System

    Cannabinoids and the Endocannabinoid System Franjo Grotenhermen Cannabinoids 2006 Abstract The human body possesses specific binding sites on the surface of many cell types for cannabinoids, and our body produces several endocannabinoids, fatty acid derivatives that bind to these...
  6. Julie Gardener

    Antidepressant-Like Activity/Modulation Of Brain Monoaminergic Transmission/Anadamide

    Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis G. Gobbi, F. R. Bambico, R. Mangieri, M. Bortolato, P. Campolongo, M. Solinas, T. Cassano, M. G. Morgese, G. Debonnel, A. Duranti, A. Tontini, G. Tarzia, M. Mor, V. Trezza, S. R...